Prelude Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.39M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $404K | Sell |
|
|||||
|
2022
Q2 | $1.4M | Buy |
|
|||||
|
2021
Q3 | – | Hold |
|
|||||
|
2021
Q2 | – | Hold |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $998K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $53K | Sell |
|
|||||
|
2019
Q3 | $584K | Buy |
|
|||||
|
2019
Q2 | $59K | Sell |
|
|||||
|
2019
Q1 | $960K | Sell |
|
|||||
|
2018
Q4 | $1.2M | Sell |
|
|||||
|
2018
Q3 | $1.26M | Buy |
|
|||||
|
2018
Q2 | $732K | Buy |
|
|||||
|
2018
Q1 | $722K | Buy |
|
|||||
|
2017
Q4 | $76K | Buy |
|
|||||
|
2017
Q3 | $58K | Buy |
|
|||||
|
2017
Q2 | $29K | Sell |
|
|||||
|
2017
Q1 | $370K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $41K | Sell |
|
|||||
|
2014
Q4 | $338K | Hold |
|
|||||
|
2014
Q3 | $343K | Hold |
|
|||||
|
2014
Q2 | $357K | Buy |
|